397 related articles for article (PubMed ID: 17192738)
21. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
Rios LA; Panhoca R; Mattos D; Srugi M; Bruschini H
Neurourol Urodyn; 2007; 26(6):773-8. PubMed ID: 17638305
[TBL] [Abstract][Full Text] [Related]
22. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin.
Welk BK; Teichman JM
Urology; 2008 Jan; 71(1):67-70. PubMed ID: 18242367
[TBL] [Abstract][Full Text] [Related]
23. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.
Parsons CL
Urology; 2005 Jan; 65(1):45-8. PubMed ID: 15667861
[TBL] [Abstract][Full Text] [Related]
24. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
25. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
[TBL] [Abstract][Full Text] [Related]
26. Severity of interstitial cystitis symptoms and quality of life in female patients.
El Khoudary SR; Talbott EO; Bromberger JT; Chang CC; Songer TJ; Davis EL
J Womens Health (Larchmt); 2009 Sep; 18(9):1361-8. PubMed ID: 19743907
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup.
Peters KM; Diokno AC; Steinert BW; Gonzalez JA
J Urol; 1998 May; 159(5):1483-6; discussion 1486-7. PubMed ID: 9554338
[TBL] [Abstract][Full Text] [Related]
28. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
29. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
30. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome.
Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG
BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619
[TBL] [Abstract][Full Text] [Related]
31. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis.
Kuo HC
Urol Int; 2005; 75(2):170-4. PubMed ID: 16123573
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
Liu HT; Kuo HC
BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
[TBL] [Abstract][Full Text] [Related]
33. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Navarra P; Scivoletto G; Mearini E; Porena M
J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393
[TBL] [Abstract][Full Text] [Related]
34. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome.
Lee WC; Chuang YC; Lee WC; Chiang PH
Kaohsiung J Med Sci; 2011 Oct; 27(10):437-40. PubMed ID: 21943815
[TBL] [Abstract][Full Text] [Related]
35. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
Sriplakich S; Promwatcharanon K
J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
[TBL] [Abstract][Full Text] [Related]
36. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
Shao Y; Shen ZJ; Rui WB; Zhou WL
Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087
[TBL] [Abstract][Full Text] [Related]
37. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
38. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.
Guo C; Yang B; Gu W; Peng B; Xia S; Yang F; Wen D; Geng J; Zhang Y; Zheng J
PLoS One; 2013; 8(12):e82591. PubMed ID: 24376550
[TBL] [Abstract][Full Text] [Related]
39. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study.
Constantinides C; Manousakas T; Nikolopoulos P; Stanitsas A; Haritopoulos K; Giannopoulos A
BJU Int; 2004 Jun; 93(9):1262-6. PubMed ID: 15180619
[TBL] [Abstract][Full Text] [Related]
40. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.
Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB
J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
